Vanguard Capital Management
BOLD

Vanguard Capital Management’s Boundless Bio BOLD Stock Holding History

Vanguard Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
614,923
+17,731
+3% +$27.3K ﹤0.01% 3497
2026
Q1 		$657K Buy
+597,192
New +$698K ﹤0.01% 3631

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Vanguard Capital Management's BOLD Position: Q2 2026 in Review

Vanguard Capital Management increased its Boundless Bio (BOLD) stake by 3% in Q2 2026, buying an estimated $27.3K and bringing the position to 614,923 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3497.

Vanguard Capital Management first reported a position in BOLD in Q1 2026 and has held it in 2 quarters since. 34 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Vanguard Capital Management held 614,923 shares of Boundless Bio worth $1.54M as of Q2 2026.
  • Vanguard Capital Management bought 17,731 Boundless Bio shares in Q2 2026, an estimated $27.3K.
  • Boundless Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3497 holding.
  • Vanguard Capital Management first reported a position in Boundless Bio in Q1 2026 and has held it in 2 quarters since.
  • 34 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.